Loading...
Search Filters
Date Range
toReport Types
Condition
See all (39)
Region of the Body
See all (20)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 20 of 472
Non-inferior efficacy of topical TXA to IV TXA in total knee arthroplasty patients
J Arthroplasty. 2014 Aug;29(8):1528-31
Combination of intravenous and topical TXA improves outcomes following primary TKA
J Arthroplasty. 2014 Dec;29(12):2342-6.
Similar blood loss and lower cost with oral TXA vs. both IA TXA and IV TXA in total hip arthroplasty
J Arthroplasty. 2018 Mar;33(3):786-793
Intracapsular and intravenous administration for TXA similar in efficacy and safety in TKA
J Arthroplasty. 2016 Nov;31(11):2452-2457
Large-scale trial comparing topical and intravenous TXA efficacy in total knee arthroplasty
J Bone Joint Surg Am. 2018 Jun 20;100(12):1023-1029
IV & topical TXA similarly safe & effective for reducing blood loss and transfusion in TKA
J Orthop. 2016 Mar 26;13(3):127-31
Lower blood loss with IV+IA TXA versus IV TXA alone following total knee arthroplasty
J Bone Joint Surg Am. 2016 May 18;98(10):835-41
Combined IV-topical TXA versus IV TXA alone in patients undergoing revision THA
J Arthroplasty. 2016 Nov;31(11):2548-2553
Combined IV-IA TXA further reduces blood loss versus IV TXA alone, but does not reduce transfusion
BMC Musculoskelet Disord. 2018 Sep 7;19(1):321. doi: 10.1186/s12891-018-2181-9
Topical and intravenous tranexamic acid equally effective in total knee arthroplasty
Knee. 2014 Dec;21(6):987-993
TXA effective in reducing blood loss and transfusion in TKA vs. routine hemostasis
Arch Orthop Trauma Surg. 2015 Jul;135(7):1017-25
Periarticular and intravenous TXA comparable in blood loss and transfusion rates after TKA
BMC Musculoskelet Disord. 2016 Jul 26;17:313.
Showing 1 - 20 of 472